
    
      A two-centred randomized, multi-blind (i.e. patients, caregivers, data collectors, outcome
      assessors, data managers and analysts), placebo-controlled clinical trial intended to
      evaluate the efficacy and safety of Bio-K+ (Lactobacillus acidophilus CL1285, Lactobacillus
      casei LBC80R and Lactobacillus rhamnosus CLR2) in the prevention of AAD in hospitalized
      children 1 year to 17 years of age administered IV antibiotics.
    
  